Manchester Financial’s Avita Medical RCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-20
Closed 510
2021
Q1
$0 Hold
20
﹤0.01% 756
2020
Q4
$0 Hold
20
﹤0.01% 643
2020
Q3
$1K Hold
20
﹤0.01% 530
2020
Q2
$1K Buy
+20
New +$612 ﹤0.01% 498
2020
Q1
Sell
-40
Closed -$2K 589
2019
Q4
$2K Buy
+40
New +$1.66K ﹤0.01% 506

Other funds holding RCEL

Manchester Financial's RCEL Position: Q2 2021 in Review

Manchester Financial sold out of Avita Medical (RCEL) in Q2 2021, closing a stake of 20 shares.

Manchester Financial first reported a position in RCEL in Q4 2019 and held it in 5 quarters. The position peaked at $2K in Q4 2019. 71 funds tracked by Wall St. Rank hold RCEL as of Q2 2021.

  • Manchester Financial reported no remaining Avita Medical position as of Q2 2021 after selling out during the quarter.
  • Manchester Financial sold 20 Avita Medical shares in Q2 2021.
  • Manchester Financial first reported a position in Avita Medical in Q4 2019 and held it in 5 quarters.
  • Manchester Financial's Avita Medical position peaked at $2K in Q4 2019.
  • 71 funds tracked by Wall St. Rank held Avita Medical as of Q2 2021.

Based on Manchester Financial's 13F filing for Q2 2021, filed 21 Jul 2021.